INSIGHTS
-
Long‑Term Chlorpyrifos Exposure Raises Parkinson’s Risk – What Residents Near Farms Should Know
Researchers found that people who lived or worked near sustained chlorpyrifos use had over 2.5 times the risk of developing Parkinson’s disease compared with those with little or no exposure. Lab work in mice and zebrafish also showed movement problems, loss of dopamine neurons, brain inflammation, and buildup of alpha‑synuclein – the same hallmarks seen…
-
New FDA Warning: Carbidopa & Levodopa Can Cause Vitamin B6 Deficiency and Seizures – What Patients Need to Know
The FDA has told drug makers to add a warning to all products containing carbidopa & levodopa – the most common medicines for Parkinson’s symptoms – because these drugs can lower vitamin B6 (pyridoxine) and have been linked to vitamin B6 deficiency–associated seizures. The agency reviewed reports and asked manufacturers to update prescribing information so…
-
Icotyde – a new psoriasis treatment pill
The U.S. Food and Drug Administration has approved Icotyde (icotrokinra) for the treatment of moderate-to-severe plaque psoriasis in adults and in adolescents 12 years and older who weigh at least 40 kg. This is notable because Icotyde is an oral, once-daily medication that targets the IL‑23 receptor, a key part of the immune pathway that…
-
BIMZELX vs SKYRIZI – one stands out in a head‑to‑head trial
A new head‑to‑head study found that bimekizumab (brand name BIMZELX) produced better short‑term joint improvement than risankizumab (brand name SKYRIZI) in adults with active psoriatic arthritis (PsA). The trial’s primary measure was ACR50 – a commonly used, fairly strict standard that means a patient has achieved at least a 50% improvement in joint signs and…
-
Do magnesium supplements help sleep? What the science and data actually say
Sleep problems are common, and magnesium is one of the most frequently recommended over‑the‑counter options people turn to. The evidence is mixed but growing: observational studies link higher magnesium intake to better sleep, several randomized trials in older adults show modest improvements (especially faster sleep onset), and systematic reviews call for larger, higher‑quality trials. We’ll…
-
FDA approves first generic of Flovent HFA: what this means for people with asthma
If you or a family member uses Flovent HFA or another inhaled steroid to control asthma, this week’s news could affect how easily you get that medicine and how much it costs. The U.S. Food and Drug Administration has approved the first true generic version of Flovent HFA (fluticasone propionate) inhalation aerosol, 44 micrograms per…
-
Leucovorin as Autism treatment and the sudden rush: what the science actually says
In late 2025 a White House briefing mentioned two things that grabbed headlines: a possible link between acetaminophen (Tylenol) in pregnancy and autism, and leucovorin (also called folinic acid) as a potential treatment for some children with autism. That announcement was followed by a sharp jump in prescriptions for leucovorin and a scramble at pharmacies…
-
Universal nasal vaccine for coughs, colds and flu. How a single spray could change winter.
Imagine a single nasal spray that cuts your chances of catching the flu, COVID, the common cold, and even some bacterial lung infections – and that also calms allergic reactions that trigger asthma. That’s the bold idea behind a new line of research showing a nasal vaccine can supercharge the lungs’ frontline defenses, protecting mice…
-
Pacemaker for the Brain – How Deep Brain Stimulation May Help People Living With Parkinson’s Disease
Deep brain stimulation – often described as a “pacemaker for the brain” – has become one of the most promising medical technologies for people with Parkinson’s disease whose symptoms are no longer well‑controlled by medication alone. While it doesn’t cure the disease, it can meaningfully reduce tremors, stiffness, and movement problems that interfere with daily…
-
A New Path to Stopping Epstein‑Barr Virus: How Scientists Created Human Antibodies That Block Infection
Epstein‑Barr virus (EBV) is one of the most common viruses on Earth, yet it rarely makes headlines. Most people catch it at some point in their lives, often without knowing it. But beneath its quiet reputation, EBV is linked to a surprising number of serious health problems – from infectious mononucleosis (“mono”) to certain cancers…